Lynch & Associates Compugen LTD Transaction History
Lynch & Associates
- $467 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding CGEN
# of Institutions
73Shares Held
13.1MCall Options Held
79.2KPut Options Held
12.7K-
Silverarc Capital Management, LLC1.5MShares$2.24 Million0.68% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$1.92 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.2MShares$1.79 Million1.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.09MShares$1.63 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.52 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $129M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...